Factors associated with IgG antibody response following inactivated COVID-19 vaccination in children aged 3-17 years
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background The factors affecting the vaccine-induced humoral immune response in children's groups have not been fully clarified. This study takes COVID-19 vaccination as a model to determine the factors related to the IgG seropositivity of children aged 3 to 17 after vaccination with inactivated COVID-19 vaccine. Methods This single-center retrospective study included 1,706 children aged 3 to 17 who were vaccinated with at least one dose of inactivated whole virus COVID-19 vaccine between July 2021 and November 2022 (306 with one dose, 1,400 with two doses). The colloidal gold method was used to qualitatively evaluate the IgG antibody response. Data such as demographic characteristics, disease after vaccination, sports activities during vaccination, underlying diseases, medication, vitamin D supplementation and adverse reactions were collected through structured questionnaires. Univariate and multivariate logistic regression were used to identify factors related to seroconversion, and subgroup analysis was carried out on the two groups by age. Results In the adjusted two-dose cohort, compared with children aged 3–5 years, those aged 6–12 years (OR = 0.67, 95% CI 0.52–0.87) and 13–17 years (OR = 0.12, 95% CI 0.07–0.21) had lower odds of seroconversion. Post-vaccination illness (OR = 3.94, 95% CI 2.62–5.91), vitamin D supplementation (OR = 1.28, 95% CI 1.01–1.62), and adverse reactions (OR = 2.52, 95% CI 1.67–3.80) were significantly associated with higher odds, whereas peri-vaccination physical activity (OR = 0.51, 95% CI 0.38–0.69) was significantly associated with lower odds. In the adjusted one-dose cohort, age 6–12 years (vs. 3–5 years: OR = 0.12, 95% CI 0.05–0.28) and post-vaccination illness (OR = 10.81, 95% CI 4.55–25.67) remained significantly associated with seroconversion. In age-stratified analyses of the two-dose cohort, adverse reactions were significantly associated with lower odds in children aged 3–5 years (OR = 0.26, 95% CI 0.09–0.80) but higher odds in those aged 6–12 years (OR = 2.30, 95% CI 1.40–3.76) and 13–17 years (OR = 12.93, 95% CI 4.52–37.01). Conclusion Age, acute diseases after vaccination, strenuous sports activities before and after vaccination, vitamin D supplementation, and adverse reactions are all independently related to the IgG seroconversion after children's inactivated COVID-19 vaccine.
Source: Frontiers in Medicine
Authors: Linlin Wang(Conceptualization, Investigation, Writing – original draft, Writing – review & editing), Xinfeng Zhao(Conceptualization, Investigation, Validation, Writing – review & editing), Gongbo Zeng(Conceptualization, Investigation, Writing – review & editing), Suling Wu(Conceptualization, Project administration, Validation, Writing – review & editing)
Institution: Hangzhou Children's Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: COVID-19 vaccines, inactivated whole virus vaccine, IgG antibody response, seroconversion, children, vitamin D supplementation, vaccine adverse reactions, physical activity, age differences, vaccine dosing, SARS-CoV-2, vaccine safety and efficacy, children with chronic illness, children with comorbidities
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234291990
